单克隆B细胞淋巴细胞症:血液学家不应忽视的沉默克隆
Andrea Serafin1, Emanuela Sant'Antonio2, Fabrizio Mavilia2
1Hematology Unit, Department of Medicine, University of Padova, Padova, Italy.
Hematological oncology
|June 15, 2025
概括
单克隆B细胞淋巴细胞病 (MBL) 涉及小克隆B细胞. 高计数的MBL (HC-MBL) 可能会发展为白血病,而低计数的MBL (LC-MBL) 需要进一步研究其免疫影响.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 单克隆B细胞淋巴细胞病 (MBL) 的特点是,在周围血液中,B细胞的克隆数量很小.
- 根据克隆大小,MBL被分为低数 (LC-MBL) 和高数 (HC-MBL) 的亚型.
研究的目的:
- 区分LC-MBL和HC-MBL的临床意义和影响.
- 突出MBL对免疫功能和癌症易感性的更广泛影响.
主要方法:
- 现有文献的审查和MBL亚型的分类.
- 对进展风险,免疫功能障碍和相关健康风险的分析.
主要成果:
- HC-MBL与慢性淋巴细胞白血病 (CLL) 具有共同特征,每年有1-2%的进展风险,对感染,恶性瘤的易感性增加,疫苗反应减少.
- LC-MBL的进展概率较低,但其对免疫功能的影响需要进一步研究.
结论:
- 管理MBL需要注意免疫功能和癌症风险超越进展.
- 预防策略包括查,疫苗接种和生活方式改变对于患有MBL的人来说至关重要.
相关概念视频
Cells of the Adaptive Immune Response
4.8K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.8K
Disorders of Leukocytes
1.2K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K
Hybridoma Technology
15.4K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.4K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
B Cell Activation and Differentiation
6.9K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
6.9K


